|
1
|
Topp M, Van Meerten T, Wermke M, Lugtenburg P, Minnema M, Song K, Thieblemont C, Jiang Y, Plaks V, Kerber A, Kersten M. PRELIMINARY RESULTS OF EARLIER STEROID USE WITH AXICABTAGENE CILOLEUCEL (AXI-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.114_2630] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- M.S. Topp
- Medizinische Klinik und Poliklinik II; Universitätsklinikum Würzburg; Würzburg Germany
| | - T. Van Meerten
- Department of Hematology; University Medical Center Groningen on behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium); Groningen Netherlands
| | - M. Wermke
- Medical Department I; University Hospital Carl Gustav Carus; Dresden Germany
| | - P.J. Lugtenburg
- Lunenburg Lymphoma Phase I/II Consortium - HOVON /LLPC; Erasmus MC; Rotterdam Netherlands
| | - M.C. Minnema
- Department of Medical Oncology; University Medical Center Utrecht on behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium); Utrecht Netherlands
| | - K.W. Song
- Division of Hematology
- Department of Medicine; The University of British Columbia; Vancouver Canada
| | - C. Thieblemont
- Service Onco-Hematologie; Hôpital Saint Louis; Paris France
| | - Y. Jiang
- Biostatistics; Kite, a Gilead Company; Santa Monica United States
| | - V. Plaks
- Cell Biology; Kite, a Gilead Company; Santa Monica United States
| | - A. Kerber
- Clinical Development; Kite, a Gilead Company; Santa Monica United States
| | - M.J. Kersten
- Internal Medicine; Academic Medical Center University of Amsterdam on behalf of HOVON/LLPC (Lunenburg Lymphoma Phase I/II Consortium); Amsterdam Netherlands
| |
Collapse
|